After twenty years of seeing patients at SW1 Clinic, I’ve developed the habit of looking back through patient records when someone asks me to explain why they’ve aged the way they have. The question is almost always framed as genetics — “my mother looks old” or “it runs in the family.” Sometimes that’s correct. But when I look at the data in front of me — blood panels, treatment history, lifestyle conversations — a different pattern usually emerges.
The women who are consistently appearing younger than their chronological age when they sit across from me are not all the same genetic type. They are not all wealthy enough to afford extensive treatment. They are not all exercising like athletes or eating perfectly.
They are almost all, to a degree that I have found striking, hormonally supported.
What hormonal support actually means
I am not talking exclusively about hormone replacement therapy, though that is part of the picture. I am talking about a much broader category: the degree to which a woman’s hormonal environment — oestrogen, progesterone, testosterone, cortisol, thyroid, insulin — is within functional ranges and relatively stable.
Women who age well tend to have one or more of the following in common: they exercise regularly in a way that supports hormonal balance, they sleep adequately, they have well-controlled insulin sensitivity, their thyroid function is optimised, and — increasingly, in my patient population — they have approached perimenopause and menopause with some degree of medical support rather than simply enduring it.
The women who appear significantly older than their age, conversely, tend to have hormonal environments that have been in disarray for years — often silently, because the symptoms of hormonal imbalance in midlife are frequently attributed to stress, poor sleep, or simply “getting older,” rather than being investigated as the treatable biochemical events they are.
The oestrogen connection to facial appearance
This is worth being direct about, because I think there is still a widespread cultural reluctance — particularly in Asian communities — to acknowledge the degree to which oestrogen decline changes the face.
Oestrogen maintains skin thickness, collagen content, glycosaminoglycan levels (which determine skin hydration), and sebaceous gland activity. When oestrogen declines — which begins in perimenopause, often in the mid-to-late 40s in Asian women — skin loses collagen at an accelerated rate, hydration decreases, sebum production drops, and the dermis thins. The face looks simultaneously drier, flatter, and more lined [1].
I see this transition in my patients in real time. There is sometimes a period of two to three years in the early perimenopause where the skin changes more rapidly than anything else in the preceding decade. Lines that weren’t visible deepen quickly. The face loses the quality of presence it had.
Women who approach this transition with hormonal optimisation — whether through lifestyle interventions that preserve oestrogen’s downstream effects, or through hormone therapy in appropriate candidates — age differently through this period than those who don’t. The skin change is attenuated. The collagen degradation is slowed. The face maintains a quality that clinical treatments can supplement but not replicate from scratch.
Why this isn’t about treatments
I want to be clear about something that might seem counterintuitive coming from someone who runs an aesthetic clinic: the women in my practice who look most consistently well are not necessarily the ones who have had the most treatments.
Treatments work well when there is a good biological foundation to work with. They produce limited or temporary results when the foundation is compromised. A patient with good hormonal health, adequate sleep, well-controlled systemic inflammation, and stable insulin sensitivity responds to aesthetic treatments dramatically better than one whose foundation is disrupted.
I’ve treated patients who had significant dermal filler, regular neurotoxin, and energy-based treatments who still looked their age or older — because the treatments were compensating for an internal environment that was continuously working against them.
Conversely, I have patients who have had minimal clinical treatment but who look genuinely younger than their years because they have, largely through intention and luck, maintained the biological conditions that support structural skin health.
The Asian-specific dimension
In Singapore and across Southeast Asia, the cultural silence around women’s hormonal health in midlife is a real clinical problem.
Menopause is not openly discussed in most Chinese, Malay, or Indian families. The symptoms — sleep disruption, mood changes, skin changes, weight redistribution, reduced libido — are frequently attributed to ageing, stress, or personal failings rather than to a physiological transition with medical management options. Many of my Asian patients have been experiencing significant perimenopausal symptoms for three to five years before they present in a context where anyone asks about hormones.
By the time they arrive, the skin changes are already established. The bone density implications may already be accumulating. The metabolic trajectory may already have shifted. This is not inevitable. It is a consequence of cultural silence and undereducated medicine.
Research in Asian populations specifically has found that the hormonal decline in East and Southeast Asian women is associated with distinct patterns of facial ageing — including more pronounced periorbital changes and earlier mid-face descent — that correlate with hormone levels at the time of the relevant decline [2].
What you can actually do
Get your hormones assessed. If you’re in your mid-to-late 40s and you’re noticing changes in your skin, sleep, weight, or energy that you haven’t been able to explain or address, a full hormone panel is not an optional extra — it’s foundational information.
The panel should include: oestradiol, FSH, LH, progesterone (where cycle phase is interpretable), total and free testosterone, DHEA-S, thyroid function, and fasting insulin. This is not a specialist panel. Any GP or aesthetic physician in Singapore can order this.
If the results indicate hormonal decline or imbalance, that is a conversation worth having with a physician who takes hormonal optimisation seriously. In Singapore, this is still not the default conversation — it requires seeking it out. My book Get Your Sexy Back covers the hormone-ageing connection in detail, specifically for women navigating perimenopause.
I also discuss this on my podcast Skin, Honestly — because the conversation needs to be normalised, not whispered.
Genetics is not destiny. Neither is your age.
The women who age most gracefully are not the luckiest. They are, more often than we acknowledge, the most informed.
References
[1] Hall, G., & Phillips, T. J. (2005). Estrogen and skin: The effects of estrogen, menopause, and hormone replacement therapy on the skin. Journal of the American Academy of Dermatology, 53(4), 555–568. https://doi.org/10.1016/j.jaad.2004.08.039 [VERIFY — confirm before publishing]
[2] Tsukahara, K., et al. (2013). Skin surface topography and mechanical properties of facial skin in Japanese women during the perimenopausal period. Skin Research and Technology, 19(1), e196–e204. [VERIFY — confirm before publishing]
[3] Calleja-Agius, J., & Brincat, M. (2013). The effect of menopause on the skin and other connective tissues. Gynecological Endocrinology, 28(4), 273–277. [VERIFY — confirm before publishing]